Development
Silo Pharma, Inc.
SILO
$0.6293
$0.0315.18%
NASDAQ
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 8.77M | 9.99M | 10.68M | 11.37M | 12.33M |
Total Receivables | 70.40K | 69.20K | 68.00K | 66.80K | 800.00 |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 74.10K | 115.50K | 169.90K | 119.20K | 288.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 5.00K | 5.00K | 33.60K | 15.90K | 292.20K |
Total Current Assets | 8.92M | 10.18M | 10.95M | 11.57M | 12.91M |
|
|||||
Total Current Assets | 8.92M | 10.18M | 10.95M | 11.57M | 12.91M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 66.40K | 67.90K | 69.40K | 70.80K | 137.10K |
Total Assets | 8.99M | 10.25M | 11.02M | 11.64M | 13.05M |
|
|||||
Total Accounts Payable | 606.70K | 689.10K | 373.10K | 208.50K | 223.60K |
Total Accrued Expenses | -- | 359.00K | 287.20K | 155.70K | 16.40K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 72.10K | 72.10K | 72.10K | 72.10K | 72.10K |
Total Other Current Liabilities | 72.10K | 72.10K | 72.10K | 72.10K | 72.10K |
Total Current Liabilities | 678.80K | 1.12M | 732.40K | 436.30K | 312.20K |
|
|||||
Total Current Liabilities | 678.80K | 1.12M | 732.40K | 436.30K | 312.20K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 811.70K | 829.70K | 847.80K | 865.80K | 883.80K |
Total Liabilities | 1.49M | 1.95M | 1.58M | 1.30M | 1.20M |
|
|||||
Common Stock & APIC | 17.41M | 17.41M | 17.52M | 17.51M | 17.36M |
Retained Earnings | -9.75M | -9.09M | -8.08M | -7.17M | -5.51M |
Treasury Stock & Other | -162.70K | -19.50K | 5.20K | -- | -- |
Total Common Equity | 7.50M | 8.30M | 9.44M | 10.34M | 11.85M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.50M | 8.30M | 9.44M | 10.34M | 11.85M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 7.50M | 8.30M | 9.44M | 10.34M | 11.85M |
|